Paul Hastings / UNITED STATES
provides a qualitative rating based on Partner's clients feedback assessment
The indicator measures the ability to convey information to another effectively and efficiently.
The indicator measures knowledge of, and skill in the exercise of, practices required for successful accomplishment of a business, job, or task.
The indicator measures the comparison of what is actually performed with what can be achieved with the same consumption of resources.
The indicator measures the degree to which objectives are achieved and the extent to which targeted problems are solved.
Perceived Added Value
The indicator measures the evaluation of the difference between the cost of the tax / legal counsel and the contribution of the professional to achieve the business objectives of the matter.
Viking Therapeutics's $175.8 Million Public Offering of StockPaul Hastings represented Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, in its $175.8 million underwritten public offering of common stock.
Viking Therapeutics, Inc.'s $63.25 Million Initial Public OfferingPaul Hastings LLP represented Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, in its $63.25 million underwritten public offering of common stock.
Menlo Technologies' Acquisition of SSi ConsultingPaul Hastings LLP represented Menlo Technologies in its acquisition of SSi Consulting, a leading financial management software (ERP) implementation and consulting firm headquartered in Vienna, VA.
Results are based upon public information and may undervalue a law firm's and/or a lawyer's professional experience and client portfolio.